1-4 of 4
Julian A. Abrams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus

Available to Purchase
Julian A. Abrams, Armando Del Portillo, Caitlin Hills, Griselda Compres, Richard A. Friedman, Bin Cheng, John Poneros, Charles J. Lightdale, Rachel De La Rue, Massimiliano di Pietro, Rebecca C. Fitzgerald, Antonia Sepulveda, Timothy C. Wang
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2021) 14 (6): 675–682.
https://doi.org/10.1158/1940-6207.CAPR-21-0050
Published: 01 June 2021
View articletitled, Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus
Open the PDF for Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus in another window
Includes: Supplementary data
Journal Articles

Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma

Free
Raphael Schellnegger, Anne Quante, Susanne Rospleszcz, Martina Schernhammer, Bettina Höhl, Moritz Tobiasch, Agnieszka Pastula, Anna Brandtner, Julian A. Abrams, Konstantin Strauch, Roland M. Schmid, Michael Vieth, Timothy C. Wang, Michael Quante
Journal: Cancer Prevention Research
Series: Author Choice
Cancer Prev Res (Phila) (2017) 10 (1): 55–66.
https://doi.org/10.1158/1940-6207.CAPR-16-0117
Published: 05 January 2017
View articletitled, Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma
Open the PDF for Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus

Available to Purchase
Andrew K. Joe, Felice Schnoll-Sussman, Robert S. Bresalier, Julian A. Abrams, Hanina Hibshoosh, Ken Cheung, Richard A. Friedman, Chung S. Yang, Ginger L. Milne, Diane D. Liu, J. Jack Lee, Kazeem Abdul, Michelle Bigg, Jessica Foreman, Tao Su, Xiaomei Wang, Aqeel Ahmed, Alfred I. Neugut, Esther Akpa, Scott M. Lippman, Marjorie Perloff, Powel H. Brown, Charles J. Lightdale
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (12): 1131–1137.
https://doi.org/10.1158/1940-6207.CAPR-14-0274-T
Published: 03 December 2015
View articletitled, Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus
Open the PDF for Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus in another window
Journal Articles

Abstract C48: Phase Ib randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in patients with Barrett's esophagus

Free
Andrew K. Joe, Felice Schnoll-Sussman, Robert S. Bresalier, Julian A. Abrams, Hanina H. Hibshoosh, Kenneth Cheung, Richard A. Friedman, Chung S. Yang, Ginger Milne, Diane D. Liu, Kazeem Abdul, Michelle Bigg, Jessica Foreman, Shing Lee, Tao Su, Aqeel Ahmed, Alfred I. Neugut, Esther Akpa, Scott Lippman, Marjorie Perloff, Powel H. Brown, Charles J. Lightdale
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C48.
https://doi.org/10.1158/1940-6215.PREV-13-C48
Published: 28 August 2014
View articletitled, Abstract C48: Phase Ib randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in patients with Barrett's esophagus